Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT00541034 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: pentostatin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]